Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine

被引:18
|
作者
Wu, Fan [1 ]
Yuan, Xiao-Yi [1 ]
Huang, Wei-Shan [1 ]
Chen, Ying-Hua [1 ]
机构
[1] Tsinghua Univ, Immunol Lab, Dept Biol, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China
关键词
Influenza virus; Combined vaccination; M2e; Split influenza vaccine; Heterosubtypic protection; PANDEMIC CONTROL STRATEGIES; EXTRACELLULAR DOMAIN; AVIAN INFLUENZA; A H5N1; VIRUS; IMMUNITY; PROTEIN; MICE; INFECTION;
D O I
10.1016/j.vaccine.2008.11.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is urgent need to develop influenza vaccines with broad-spectrum protection against the potential influenza pandemic. The extracellular domain of influenza M2 protein (M2e) is considered as an appropriate target to induce heterosubtypic protection. We investigated the immunity and protection induced by combined vaccination with synthetic M2e peptide and traditional split influenza vaccine. The combined vaccination was able to induce similar strain-specific hemagglutinin inhibition (HI) antibodies as vaccination of split virus alone. However, aluminum-adjuvant but not oil-in-water-emulsion adjuvant combined vaccination was able to induce high titers of anti-M2e antibodies and provoke M2e-specific T lymphocyte response. Furthermore, we found that the addition of M2e peptide greatly enhanced the cross-protective efficacy of split virus in aluminum adjuvant but slightly weakened the efficacy of vaccination in oil-in-water-emulsion adjuvant. Moreover, aluminum-adjuvant combined vaccination conferred complete cross-protection against heterosubtypic influenza virus. According to the results, we suggest that the M2e peptide should be added into split influenza vaccine in the preparation for the potential influenza pandemic. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6095 / 6101
页数:7
相关论文
共 50 条
  • [1] M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection
    Tao, Wenqian
    Gill, Harvinder S.
    VACCINE, 2015, 33 (20) : 2307 - 2315
  • [2] An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge
    Ji-Hong Ma
    Fu-Ru Yang
    Hai Yu
    Yan-Jun Zhou
    Guo-Xin Li
    Meng Huang
    Feng Wen
    Guangzhi Tong
    Virology Journal, 10
  • [3] An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge
    Ma, Ji-Hong
    Yang, Fu-Ru
    Yu, Hai
    Zhou, Yan-Jun
    Li, Guo-Xin
    Huang, Meng
    Wen, Feng
    Tong, Guangzhi
    VIROLOGY JOURNAL, 2013, 10
  • [4] Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine
    Carignan, Damien
    Therien, Ariane
    Rioux, Gervais
    Paquet, Genevieve
    Gagne, Marie-Eve Laliberte
    Bolduc, Marilene
    Savard, Pierre
    Leclerc, Denis
    VACCINE, 2015, 33 (51) : 7245 - 7253
  • [5] Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform
    Denis, Jerome
    Acosta-Ramirez, Elizabeth
    Zhao, Yinghi
    Hamelin, Marie-Eve
    Koukavica, Irena
    Baz, Mariana
    Abed, Yacine
    Savard, Christian
    Pare, Christine
    Macias, Constantino Lopez
    Boivin, Guy
    Leclerc, Denis
    VACCINE, 2008, 26 (27-28) : 3395 - 3403
  • [6] A single-shot vaccine approach for the universal influenza A vaccine candidate M2e
    Kavishna, Ranmali
    Kang, Tha Yang
    Vacca, Maurizio
    Chua, Benson Yen Leong
    Park, Hae-Young
    Tan, Peck Szee
    Chow, Vincent Tk
    Lahoud, Mireille H.
    Alonso, Sylvie
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (13)
  • [7] Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA)
    Mu, Xupeng
    Hu, Kebang
    Shen, Mohan
    Kong, Ning
    Fu, Changhao
    Yan, Weiqun
    Wei, Anhui
    JOURNAL OF VIROLOGICAL METHODS, 2016, 228 : 84 - 90
  • [8] Co-Delivery of M2e Virus-Like Particles with Influenza Split Vaccine to the Skin Using Microneedles Enhances the Efficacy of Cross Protection
    Kim, Min-Chul
    Kim, Ki-Hye
    Lee, Jeong Woo
    Lee, Yu-Na
    Choi, Hyo-Jick
    Jung, Yu-Jin
    Kim, Yu-Jin
    Compans, Richard W.
    Prausnitz, Mark R.
    Kang, Sang-Moo
    PHARMACEUTICS, 2019, 11 (04):
  • [9] Targeting M2e to DEC-205 induces an enhanced serum antibody-dependent heterosubtypic protection against influenza A virus infection
    Padilla-Quirarte, H. O.
    Badillo-Godinez, O.
    Gutierrez-Xicotencatl, L.
    Acevedo-Betancur, Y.
    Luna-Andon, J. D.
    Montiel-Hernandez, J. L.
    Lopez-Guerrero, D. V.
    Esquivel-Guadarrama, F.
    VACCINE, 2019, 37 (19) : 2624 - 2633
  • [10] High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin
    Mardanova, Eugenia S.
    Kotlyarov, Roman Y.
    Kuprianov, Victor V.
    Stepanova, Liudmila A.
    Tsybalova, Liudmila M.
    Lomonossoff, George P.
    Ravin, Nikolai V.
    BIOENGINEERED, 2016, 7 (01) : 28 - 32